SCHEMBL25560665

SCHEMBL25560665

CN(Cc1ccc2ncccc2c1)C(=O)OC(C)(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP30 Q70CQ3 1/20 0.48
▸ PDK1 Q15118 2/20 0.46
▸ MAPK1 P28482 2/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ ALOX15 P16050 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ AGTR2 P50052 1/20 0.44
▸ TNF P01375 1/20 0.43
▸ NOD2 Q9HC29 1/20 0.43
▸ NOD1 Q9Y239 1/20 0.43
▸ ANO1 Q5XXA6 1/20 0.43
▸ HDAC3 O15379 2/20 0.42
▸ SPR P35270 1/20 0.41
▸ HTR2C P28335 1/20 0.41
▸ SLC6A4 P31645 1/20 0.41
▸ PLK1 P53350 1/20 0.41
▸ GLS O94925 1/20 0.41
▸ CHKA P35790 1/20 0.40
▸ RECQL P46063 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30257434 1.00 USP30 (0.48) USP30PDK1MAPK1ALDH1A1RAB9A
SCHEMBL18701602 0.84 USP30 (0.51) USP30PDK1MAPK1ALDH1A1RAB9A
SCHEMBL18711465 0.82 USP30 (0.53) USP30PDK1MAPK1ALDH1A1RAB9A
SCHEMBL23930126 0.82 PDK1 (0.56) USP30PDK1MAPK1ALDH1A1RAB9A
SCHEMBL20794554 0.78 HTR2C (0.43) ALDH1A1HTR2CSLC6A4GLSPOLB
SCHEMBL17186108 0.78 HTT (0.49) ALDH1A1RAB9AALOX15HTTPLK1
SCHEMBL17886754 0.78 PDK1 (0.58) USP30PDK1MAPK1ALDH1A1RAB9A
SCHEMBL17886955 0.77 ALDH1A1 (0.49) USP30ALDH1A1RAB9AHTTANO1
SCHEMBL18583568 0.77 ALDH1A1 (0.51) USP30PDK1ALDH1A1RAB9AALOX15
SCHEMBL30257581 0.77 NAMPT (0.50) ALDH1A1ALOX15HTTANO1HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115605477-B Pyrazolo [1,5-a ] pyridine derivative, preparation method, composition and application thereof 深圳众格生物科技有限公司 2024-07-05 — — CN disclosed
US-20230159523-A1 PYRAZOLO[1,5-A]PYRIDINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND COMPOSITION AND USE THEREOF SHENZHEN ZHONGGE BIOLOGICAL TECHNOLOGY CO., LTD. (CN) 2023-05-25 — — US disclosed
CN-115605477-A Pyrazolo [1,5-a ] pyridine derivative and preparation method, composition and application thereof 深圳众格生物科技有限公司(CN) 2023-01-13 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159523-A1 PYRAZOLO[1,5-A]PYRIDINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND COMPOSITION AND USE THEREOF NCOA4, CCDC47, CCDC6 USP30 2424/4885PDK1 112/4885MAPK1 888/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback